New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 14, 2014
06:44 EDTTAPMolson Coors initiated with an Outperform at Credit Suisse
Target $84.
News For TAP From The Last 14 Days
Check below for free stories on TAP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 19, 2014
06:03 EDTTAPStocks with implied volatility movement; TAP RSH
Stocks with implied volatility movement; Molson Coors (TAP) 31, RadioShack (RSH) 247 according to iVolatility.
September 18, 2014
05:59 EDTTAPMolson Coors implied volatility of 34 at upper end of index mean range
September 17, 2014
11:16 EDTTAPOptions with increasing implied volatility:
Options with increasing implied volatility: WB SDRL TAP AGNC IYR SKX
10:48 EDTTAPHigh option volume stocks
Subscribe for More Information
05:56 EDTTAPMolson Coors implied volatility of 33 at upper end of index mean range
September 16, 2014
17:14 EDTTAPPepsiCo, Molson Coors still look inexpensive, Barron's says
PepsiCo (PEP) and Molson Coors (TAP) both look enticing and look ready to head higher, Barron's argues in its 'Barron's Take' column. Both companies look inexpensive, when you consider growth prospects and their reasonable valuations, the paper adds. Reference Link
10:50 EDTTAPOptions with increasing implied volatility
Subscribe for More Information
09:59 EDTTAPOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: ACI Worldwide (ACIW) initiated with a Neutral at Sterne Agee... ADP (ADP) initiated with a Market Perform at Bernstein... ANSYS (ANSS) initiated with a Sector Perform at RBC Capital... Accenture (ACN) initiated with a Market Perform at Bernstein... Blackhawk (HAWK) initiated with a Neutral at Sterne Agee... Coca-Cola (KO) initiated with a Market Perform at Cowen... Cognizant (CTSH) initiated with an Outperform at Bernstein... Constellation Brands (STZ) initiated with a Market Perform at Cowen... Dr Pepper Snapple (DPS) initiated with a Market Perform at Cowen... GenCorp (GY) initiated with a Hold at KeyBanc... Global Payments (GPN) initiated with a Neutral at Piper Jaffray... GoPro (GPRO) initiated with a Buy at Cleveland Research... Green Dot (GDOT) initiated with a Neutral at Sterne Agee... Lionsgate (LGF) initiated with a Buy at ISI Group... MEDNAX (MD) initiated with a Neutral at SunTrust... MasterCard (MA) initiated with a Buy at Sterne Agee... Molson Coors (TAP) initiated with an Outperform at Cowen... Monster Beverage (MNST) initiated with a Market Perform at Cowen... NetSuite (N) initiated with an Outperform at RBC Capital... Oracle (ORCL) assumed with a Sector Perform at RBC Capital... PepsiCo (PEP) initiated with an Outperform at Cowen... SAP (SAP) initiated with a Sector Perform at RBC Capital... Teekay (TK) initiated with a Hold at Deutsche Bank... Tesla (TSLA) initiated with a Buy at ISI Group... Visa (V) initiated with a Buy at Sterne Agee... Western Union (WU) initiated with a Neutral at Sterne Agee... Workday (WDAY) initiated with an Outperform at RBC Capital... Yelp (YELP) initiated with a Neutral at RW Baird... Zillow (Z) initiated with an Overweight at Stephens... zulily (ZU) initiated with an Outperform at RW Baird.
05:52 EDTTAPStocks with implied volatility top IV index mean; TAP PBR
Subscribe for More Information
September 15, 2014
17:09 EDTTAPOn The Fly: Closing Wrap
Stocks on Wall Street were mixed to begin the week, as the Dow managed to register mild gains but the Nasdaq was weighed down by slides in a number of so-called "momentum stocks" like Tesla (TSLA). Investors may remain cautious in the next two sessions ahead of the Fed's much anticipated rate decision and accompanying statement, which is due Wednesday. ECONOMIC EVENTS: In the U.S., New York Fed's Empire state survey for September rose to a five-year high of 27.54. Industrial production unexpectedly dipped 0.1% in August from a downwardly revised 0.2% July gain, missing the forecast for a rise of 0.3%. Capacity utilization dropped to 78.8% last month from 79.1% previously. In China, industrial output increased 6.9% in August versus the same period a year earlier, which was its weakest advance, excluding months that fell during New Year holidays, since December 2008. Chinese retail sales growth for August came in at 11.9%, missing the consensus estimate. COMPANY NEWS: Shares of Apple (AAPL) edged down 3c, or 0.03%, to $101.63 despite the company's announcement that a record 4M iPhone 6 and iPhone 6 Plus pre-orders were placed in the first 24 hours that ordering was available. Demand for the new phones exceeds the initial pre-order supply, the company added, stating that delivery of "many" iPhone pre-orders have been pushed out to October... Microsoft (MSFT) slid 45c, or 0.97%, to $46.24 after the company confirmed an agreement to acquire Mojang, the developer for the "Minecraft" video game franchise, for $2.5B... MAJOR MOVERS: Among the notable gainers was Avanir Pharmaceuticals (AVNR), which surged $5.75, or 85.31%, to $12.49 and was upgraded to Buy from Hold at Jefferies after the company announced results from its phase II clinical trial evaluating the safety and efficacy of its treatment of agitation in patients with Alzheimer's disease. Also higher was SABMiller (SBMRY), which jumped $4.72, or 8.5%, to $60.26 after the Wall Street Journal said that ABInBev (BUD) was looking to obtain financing for an acquisition of the U.K.-based brewer and Heineken (HEINY) confirmed that it rebuffed SABMiller's approach regarding a potential transaction. The news of potential consolidation in the space also drove other beer makers highers, with Molson Coors (TAP) rising $4.20, or 5.85%, to $76.00 and Boston Beer (SAM) gaining 71c, or 0.33%, to $218.47. Among the noteworthy losers was Tesla (TSLA), which dropped $25.34, or 9.08%, to $253.86 after Morgan Stanley analyst Adam Jones wrote that he agrees with the assertion of Tesla's CEO Elon Musk that the company's stock may have gotten ahead of itself. Also lower were shares of NPS Pharmaceuticals (NPSP), which fell $5.42, or 16.56%, to $27.28 after Oppennheimer and Jefferies stated that approval of its Natpara drug for hypoparathyroidism could be delayed after concerns were raised during an FDA panel meeting, even though the advisors were in favor of approving the drug. INDEXES: The Dow rose 43.63, or 0.26%, to 17,031.14, the Nasdaq dropped 48.70, or 1.07%, to 4,518.90, and the S&P 500 declined 1.41, or 0.07%, to 1,984.13.
16:16 EDTTAPMolson Coors initiated with an Outperform at Cowen
Target $89.
12:31 EDTTAPOn The Fly: Midday Wrap
Subscribe for More Information
11:06 EDTTAPOptions with increasing implied volatility
Subscribe for More Information
10:50 EDTTAPBrewers climb after Heineken turns down SABMiller
Shares of beer makers SABMiller (SBMRY) and Molson Coors (TAP) are climbing after Heineken (HEINY) confirmed that it rebuffed SABMiller's approach regarding a potential acquisition. Additionally, the Wall Street Journal reported that another company in the sector, ABInBev (BUD), was looking to obtain financing for an acquisition of U.K.-based SABMiller, but that report was refuted by CNBC's David Faber. WHAT'S NEW: Heineken announced yesterday that it has been approached by SABMiller regarding a potential acquisition, but concluded that SABMiller's proposal is non-actionable. The Heineken family has informed SABMiller of its intention to "preserve the heritage and identity of Heineken as an independent company," the beer maker stated. Meanwhile, The Wall Street Journal reported, citing an unnamed source, that ABInBev is in talks with banks about financing a takeover of SABMiller. The deal could be worth nearly $122B, the newspaper added. However, CNBC's David Faber this morning disputed the accuracy of the report, saying that ABInBev was not in talks to receive financing for a SABMiller takeover and that the companies were not in discussions about a transaction. ANALYST REACTION: In a note to investors on Saturday, ISI Group analyst Robert Ottenstein recommended buying shares of Molson Coors, SABMiller. and ABInBev. SABMiller's attempt to buy Heineken could indicate that the U.K-based company thinks that it will receive a takeover offer from ABInBev in the near-term, the analyst believes. It's likely that SABMiller expects an offer by ABInBev "in the foreseeable future," causing the British brewer to explore all strategic options, Ottenstein contended. Additionally, Ottenstein does not believe that SABMiller is looking to prevent a takeover by ABInBev and he does not expect Heineken to sell itself. Heineken's management said in 2012 that the family which controls the company takes a very long-term view of the business and is unlikely to permit it to be sold, Ottenstein stated. WHAT'S NOTABLE: In June, research firm ISI Group said that if ABInBev were to acquire SABMiller, Molson Coors would likely buy SABMiller's 58% stake in their U.S. joint venture, MillerCoors , at an attractive, very accretive price. Such a deal would provide AmInBev with a solution to U.S. anti-trust issues, the firm stated. Also in June, Molson Coors CEO Peter Swinburn said he wouldn't rule out buying SABMiller's stake in MillerCoors if it becomes available. PRICE ACTION: In mid-morning trading, Molson Coors climbed nearly 7% to $76.66, SABMiller rallied 10% to $61.24, and ABInBev gained 3% to $114.50 and Heineken rose 2% to $39.19.
09:16 EDTTAPOn The Fly: Pre-market Movers
Subscribe for More Information
September 12, 2014
10:10 EDTTAPHigh option volume stocks
Subscribe for More Information
September 9, 2014
10:27 EDTTAPMolson slips after BTIG views speculated M&A as unlikely
Subscribe for More Information
10:10 EDTTAPOn the Fly: Analyst Downgrade Summary
Subscribe for More Information
08:35 EDTTAPMolson Coors downgraded to Neutral from Buy at BTIG
BTIG downgraded Molson Coors to Neutral due to relative valuation, challenging core markets, speculated M&A unlikely to materialize, and a likely CEO transition on the horizon.
06:50 EDTTAPHeineken discussing Czech operations sale with Molson, Reuters says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use